Statin Pharmacology Revisited
Open Access
- 1 April 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cardiovascular Drugs and Therapy
- Vol. 34 (2), 225-226
- https://doi.org/10.1007/s10557-020-06951-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- State of the Art Comprehensive Review of Individual Statins, Their Differences, Pharmacology, and Clinical ImplicationsCardiovascular Drugs and Therapy, 2019
- A case of simvastatin‐induced myopathy with SLCO1B1 genetic predisposition and co‐ingestion of linagliptin and Stevia rebaudianaJournal of Clinical Pharmacy & Therapeutics, 2019
- Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side EffectsCirculation, 2018
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractEuropean Heart Journal, 2018
- Statin Responses in Chinese PatientsJournal of Atherosclerosis and Thrombosis, 2018
- Variation inPCSK9andHMGCRand Risk of Cardiovascular Disease and DiabetesThe New England Journal of Medicine, 2016
- Statin use and the risk of developing diabetes: a network meta‐analysisPharmacoepidemiology and Drug Safety, 2016
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced MyopathyClinical Pharmacology & Therapeutics, 2012
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsThe Lancet, 2010
- SLCO1B1 variants and statin-induced myopathy - A genomewide studyThe New England Journal of Medicine, 2008